Akebia Therapeutics AKBA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.92 | 0.03 | 13,514 | 6 | ||
| 2024Q4 | 1.90 | 89.83 | -0.11 | -14,307 | -23 | |
| 2024Q3 | 1.32 | 93.47 | -0.09 | -12,505 | -20 | |
| 2024Q2 | 1.02 | 135.61 | -0.04 | -8,724 | -9 | |
| 2024Q1 | 1.83 | 96.44 | -0.09 | -14,936 | -18 | |
| 2023Q4 | 1.24 | 67.62 | 0.00 | 1,374 | 1 | |
| 2023Q3 | 1.14 | 99.67 | -0.08 | -13,036 | -14 | |
| 2023Q2 | 0.92 | 94.40 | -0.05 | -8,997 | -11 | |
| 2023Q1 | 0.56 | 101.14 | -0.15 | -24,938 | -26 | |
| 2022Q4 | 0.58 | 109.79 | -0.04 | -4,869 | -6 | |
| 2022Q3 | 0.32 | 100.56 | -0.29 | -47,261 | -51 | |
| 2022Q2 | 0.35 | 98.80 | 0.16 | 33,902 | 29 | |
| 2022Q1 | 0.72 | 101.98 | -0.35 | -58,493 | -62 | |
| 2021Q4 | 2.26 | 100.85 | -0.40 | -66,155 | -71 | |
| 2021Q3 | 2.88 | 100.78 | -0.33 | -54,886 | -60 | |
| 2021Q2 | 3.79 | 101.62 | -0.52 | -79,341 | -83 | |
| 2021Q1 | 3.39 | 100.25 | -0.45 | -64,936 | -70 | |
| 2020Q4 | 2.80 | 100.85 | -0.59 | -85,403 | -87 | |
| 2020Q3 | 2.51 | 100.71 | -0.40 | -58,095 | -60 | |
| 2020Q2 | 13.58 | 100.22 | -1.31 | -173,819 | -176 |